Jet Capital Investors’s Biogen BIIB Stock Holding History

Jet Capital Investors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-165,000	Closed	-$51.6M	–	37
2016 Q3	$51.6M	Buy	165,000 +75,000	+83%	+$22.2M	3.64%	12
2016 Q2	$21.8M	Buy	+90,000	New	+$23.7M	1.41%	21

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jet Capital Investors's BIIB Position: Q2 2017 in Review

Jet Capital Investors sold out of Biogen (BIIB) in Q2 2017, closing a stake of 110,069 shares — an estimated $30.1M sold.

Jet Capital Investors first reported a position in BIIB in Q3 2016 and held it in 2 quarters. The position peaked at $30.1M in Q1 2017. 992 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

Jet Capital Investors reported no remaining Biogen position as of Q2 2017 after selling out during the quarter.
Jet Capital Investors sold 110,069 Biogen shares in Q2 2017, an estimated $30.1M.
Jet Capital Investors first reported a position in Biogen in Q3 2016 and held it in 2 quarters.
Jet Capital Investors's Biogen position peaked at $30.1M in Q1 2017.
992 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Jet Capital Investors's 13F filing for Q2 2017, filed 14 Aug 2017.